[Clinical trial of local immunomodulation with DNCB in cases of advanced melanoma of the skin].
Budzanowska
E
E
Pawlicki
M
M
D000276:Adjuvants, Immunologic; D000279:Administration, Cutaneous; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003606:Dacarbazine / Q000627:therapeutic use*; D004137:Dinitrochlorobenzene / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D009367:Neoplasm Staging; D012867:Skin / Q000187:drug effects / Q000276:immunology*; D012878:Skin Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*
D000276:Adjuvants, Immunologic; D004137:Dinitrochlorobenzene; D003606:Dacarbazine
Próba miejscowej immunomodulacji DNCB w przypadkach zaawansowanego czerniaka skóry.